These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 24386158)

  • 1. Overexpression of LIM and SH3 Protein 1 leading to accelerated G2/M phase transition contributes to enhanced tumourigenesis in oral cancer.
    Shimizu F; Shiiba M; Ogawara K; Kimura R; Minakawa Y; Baba T; Yokota S; Nakashima D; Higo M; Kasamatsu A; Sakamoto Y; Tanzawa H; Uzawa K
    PLoS One; 2013; 8(12):e83187. PubMed ID: 24386158
    [TBL] [Abstract][Full Text] [Related]  

  • 2. LASP-1 induces proliferation, metastasis and cell cycle arrest at the G2/M phase in gallbladder cancer by down-regulating S100P via the PI3K/AKT pathway.
    Li Z; Chen Y; Wang X; Zhang H; Zhang Y; Gao Y; Weng M; Wang L; Liang H; Li M; Zhang F; Zhao S; Liu S; Cao Y; Shu Y; Bao R; Zhou J; Liu X; Yan Y; Zhen L; Dong Q; Liu Y
    Cancer Lett; 2016 Mar; 372(2):239-50. PubMed ID: 26797416
    [TBL] [Abstract][Full Text] [Related]  

  • 3. LIM and SH3 domain protein 1 (LASP-1) overexpression was associated with aggressive phenotype and poor prognosis in clear cell renal cell cancer.
    Yang F; Zhou X; Du S; Zhao Y; Ren W; Deng Q; Wang F; Yuan J
    PLoS One; 2014; 9(6):e100557. PubMed ID: 24955835
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Suppression of LASP-1 attenuates the carcinogenesis of prostatic cancer cell lines: Key role of the NF-κB pathway.
    Sun W; Guo L; Shao G; Liu X; Guan Y; Su L; Zhao S
    Oncol Rep; 2017 Jan; 37(1):341-347. PubMed ID: 27840958
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Silencing of LIM and SH3 Protein 1 (LASP-1) Inhibits Thyroid Cancer Cell Proliferation and Invasion.
    Gao W; Han J
    Oncol Res; 2017 Jul; 25(6):879-886. PubMed ID: 27938497
    [TBL] [Abstract][Full Text] [Related]  

  • 6. LIM and SH3 protein 1, a promoter of cell proliferation and migration, is a novel independent prognostic indicator in hepatocellular carcinoma.
    Wang H; Li W; Jin X; Cui S; Zhao L
    Eur J Cancer; 2013 Mar; 49(4):974-83. PubMed ID: 23084841
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Overexpression of LASP-1 mediates migration and proliferation of human ovarian cancer cells and influences zyxin localisation.
    Grunewald TG; Kammerer U; Winkler C; Schindler D; Sickmann A; Honig A; Butt E
    Br J Cancer; 2007 Jan; 96(2):296-305. PubMed ID: 17211471
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The cytoskeletal protein LASP-1 differentially regulates migratory activities of choriocarcinoma cells.
    Segerer SE; Bartmann C; Kaspar S; Müller N; Kapp M; Butt E; Kämmerer U
    Arch Gynecol Obstet; 2016 Feb; 293(2):407-14. PubMed ID: 26232936
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Promotion of colorectal cancer growth and metastasis by the LIM and SH3 domain protein 1.
    Zhao L; Wang H; Liu C; Liu Y; Wang X; Wang S; Sun X; Li J; Deng Y; Jiang Y; Ding Y
    Gut; 2010 Sep; 59(9):1226-35. PubMed ID: 20660701
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Upregulated LASP-1 correlates with a malignant phenotype and its potential therapeutic role in human cholangiocarcinoma.
    Zhang H; Li Z; Chu B; Zhang F; Zhang Y; Ke F; Chen Y; Xu Y; Liu S; Zhao S; Liang H; Weng M; Wu X; Li M; Wu W; Quan Z; Liu Y; Zhang Y; Gong W
    Tumour Biol; 2016 Jun; 37(6):8305-15. PubMed ID: 26729195
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HBX protein promotes LASP-1 expression through activation of c-Jun in human hepatoma cells.
    You H; Kong F; Zhou K; Wei X; Hu L; Hu W; Luo W; Kou Y; Liu X; Chen X; Zheng K; Tang R
    J Cell Physiol; 2018 Sep; 233(9):7279-7291. PubMed ID: 29600594
    [TBL] [Abstract][Full Text] [Related]  

  • 12. LASP-1: a nuclear hub for the UHRF1-DNMT1-G9a-Snail1 complex.
    Duvall-Noelle N; Karwandyar A; Richmond A; Raman D
    Oncogene; 2016 Mar; 35(9):1122-33. PubMed ID: 25982273
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nuclear localisation of LASP-1 correlates with poor long-term survival in female breast cancer.
    Frietsch JJ; Grunewald TG; Jasper S; Kammerer U; Herterich S; Kapp M; Honig A; Butt E
    Br J Cancer; 2010 May; 102(11):1645-53. PubMed ID: 20461080
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Impact of LASP-1 expression on proliferation and tumorigenesis of human colorectal cancer cell line SW480].
    Zhao L; Ding YQ
    Zhonghua Bing Li Xue Za Zhi; 2010 Dec; 39(12):830-4. PubMed ID: 21215099
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Investigating lasp-2 in cell adhesion: new binding partners and roles in motility.
    Bliss KT; Chu M; Jones-Weinert CM; Gregorio CC
    Mol Biol Cell; 2013 Apr; 24(7):995-1006. PubMed ID: 23389630
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of LASP-1, a novel SOX9 transcriptional target, in the progression of lung cancer.
    Shi J; Guo J; Li X
    Int J Oncol; 2018 Jan; 52(1):179-188. PubMed ID: 29138807
    [TBL] [Abstract][Full Text] [Related]  

  • 17. LASP-1, regulated by miR-203, promotes tumor proliferation and aggressiveness in human non-small cell lung cancer.
    Zheng J; Wang F; Lu S; Wang X
    Exp Mol Pathol; 2016 Feb; 100(1):116-24. PubMed ID: 26683818
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of hepatitis B virus X protein in regulating LIM and SH3 protein 1 (LASP-1) expression to mediate proliferation and migration of hepatoma cells.
    Tang R; Kong F; Hu L; You H; Zhang P; Du W; Zheng K
    Virol J; 2012 Aug; 9():163. PubMed ID: 22897902
    [TBL] [Abstract][Full Text] [Related]  

  • 19. LASP-1, a novel urinary marker for detection of bladder cancer.
    Ardelt P; Grünemay N; Strehl A; Jilg C; Miernik A; Kneitz B; Butt E
    Urol Oncol; 2013 Nov; 31(8):1591-8. PubMed ID: 22481019
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nuclear localization and cytosolic overexpression of LASP-1 correlates with tumor size and nodal-positivity of human breast carcinoma.
    Grunewald TG; Kammerer U; Kapp M; Eck M; Dietl J; Butt E; Honig A
    BMC Cancer; 2007 Oct; 7():198. PubMed ID: 17956604
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.